Rentox 200U

ReNTox 200 U

Product Identification

• Name: ReNTox 200 Units (Botulinum Toxin Type A)
• Manufacturer: Pharma Research Bio, South Korea
• Form: Lyophilized white powder in a single-use clear vial
• Composition (per vial)

• Botulinum toxin type A (Clostridium botulinum) – 200 Units
• Human serum albumin – 0.5 mg to 1.0 mg
• Sodium chloride – 0.9 mg to 1.8 mg

Indications

Aesthetic

• Dynamic wrinkle correction: glabellar lines, forehead lines, crow’s feet, perioral lines, nasolabial folds, marionette lines, neck bands

Therapeutic

• Blepharospasm
• Hemifacial spasm
• Cervical dystonia (spastic torticollis)
• Focal spasticity of wrist and hand (e.g., post-stroke)
• Paralytic strabismus
• Local muscle spasticity in children with cerebral palsy (≥ 2 years)
• Primary axillary hyperhidrosis

Clinical Profile

• Onset of Action: Visible results typically within 3 days; full effect by 7–10 days
• Duration of Effect: Approximately 6–8 months; in some cases up to 12 months
• Purity & Immunogenicity: High purity, free from unnecessary proteins and gelatin; reduced risk of allergic or immune reactions
• Diffusion: Very low diffusion rate for precise targeting and reduced spread to surrounding tissues
• Target Selectivity: Reported precision up to 98.7% in muscle targeting